Oelschlager Kristen M

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · derivative · entry 7

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,922

Underlying: Common Stock · 15,961 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023.

F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023.

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,759

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,965

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · balance_after: Includes 163 shares acquired on August 30, 2024, under the Issuer's employee stock purchase plan.

SEC source: 0001447362-24-000142 · wk-form4_1725566801.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,841

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $29.70 to $30.10, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001447362-24-000142 · wk-form4_1725566801.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,091

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $28.58 to $29.44, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001447362-24-000131 · wk-form4_1723587323.xml · derivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,640

Underlying: Common Stock · 10,640 shares

Expires not disclosed

F2 · derivative.exercise_price: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date.

F2 · derivative.exercise_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date.

F2 · derivative.expiration_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date.

SEC source: 0001447362-24-000131 · wk-form4_1723587323.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,673

SEC source: 0001447362-24-000131 · wk-form4_1723587323.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,477

F1 · shares: Represents 50% of the Performance-Based Stock Units ("PSUs") granted on December 23, 2022 ("2022 PSUs") that vested based on the satisfaction of certain performance criteria as certified by the board of directors of the Issuer on August 9, 2024 (the "Initial Vesting Date").

SEC source: 0001447362-24-000123 · wk-form4_1722888983.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,836

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.23 to $24.09, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001447362-24-000123 · wk-form4_1722888983.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,061

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.14 to $23.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001447362-24-000115 · wk-form4_1722459050.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,825

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.12 to $22.02, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001447362-24-000106 · wk-form4_1720037734.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,618

F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.890 to $21.705, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 1,109 shares acquired on February 29, 2024, under the Issuer's employee stock purchase plan.

SEC source: 0001447362-24-000025 · wk-form4_1709766226.xml · derivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,243

Underlying: Common Stock · 55,243 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025.

F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025.

SEC source: 0001447362-24-000002 · wk-form4_1704316285.xml · derivative · entry 6

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,610

Underlying: Common Stock · 8,000 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested.

SEC source: 0001447362-24-000002 · wk-form4_1704316285.xml · derivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,418 shares

Expires 2028-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested.

SEC source: 0001447362-24-000002 · wk-form4_1704316285.xml · derivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,197 shares

Expires 2027-07-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested.

SEC source: 0001447362-24-000002 · wk-form4_1704316285.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-24-000002 · wk-form4_1704316285.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-24-000002 · wk-form4_1704316285.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,884

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · derivative · entry 9

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F5 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · derivative · entry 8

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,339

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · nonDerivative · entry 6

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,687

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · nonDerivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · nonDerivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,399

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · derivative · entry 7

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,883

Underlying: Common Stock · 15,961 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023.

F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023.

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,855

SEC source: 0001447362-23-000179 · wk-form4_1702427930.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 759 and 427 shares acquired on February 28, 2023, and August 31, 2023, respectively, under the Issuer's employee stock purchase plan.

SEC source: 0001447362-22-000205 · wf-form4_167243621767427.xml · derivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,178 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested.

SEC source: 0001447362-22-000205 · wf-form4_167243621767427.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · derivative · entry 7

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,509

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

F5 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · derivative · entry 6

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · nonDerivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,736

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,384

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 277 shares acquired on August 31, 2022, under Castle Biosciences' employee stock purchase plan.

SEC source: 0001447362-22-000194 · wf-form4_167096756913944.xml · derivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,844

Underlying: Common Stock · 63,844 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on December 9, 2023.

F3 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on December 9, 2023.

SEC source: 0001447362-22-000070 · wf-form4_165118889230689.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,873

F1 · shares: The reporting person acquired 6,692 shares of common stock on April 26, 2022, as consideration for the Reporting Person's equity securities of AltheaDx, Inc. ("AltheaDx"), which Castle Biosciences, Inc. ("Castle Biosciences") acquired by merger on April 26, 2022 (the "Merger") pursuant to an Agreement and Plan of Merger agreement dated April 4, 2022 (the "Merger Agreement"). Of the 6,692 shares issued to the Reporting Person in the Merger, 568 shares are currently being held in escrow and are subject to forfeiture for a specified period following the Merger to satisfy indemnification claims arising of Castle Biosciences, if any.

F2 · shares: The Merger Agreement provides that the former securityholders of AltheaDx may receive additional consideration, payable 50% in cash and 50% in shares of common stock of Castle Biosciences, based on the achievement of certain commercial milestones with related dates or performance periods through December 31, 2024 (the "Milestone Payments"). The portion of the Milestone Payments payable in shares of common stock will be valued at the volume-weighted average price for the 20 trading days ending as of the applicable determination date. The number of shares issuable is subject to certain limitations set forth in the Merger Agreement. The Reporting Person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on April 26, 2022, the effective date of the merger.

F3 · price: The number of shares issuable was determined pursuant to a formula set forth in the Merger Agreement, which provided that, for the purpose of determining the number of shares issuable, the shares of Castle Biosciences common stock would be valued at $42.54, which represents the volume weighted average share price of the stock for the 20 trading days immediately preceding the date of the Merger Agreement.

F4 · balance_after: Includes 407 shares acquired on February 28, 2022, under Castle Biosciences' employee stock purchase plan.

SEC source: 0001447362-21-000268 · wf-form4_163952988173021.xml · derivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

SEC source: 0001447362-21-000268 · wf-form4_163952988173021.xml · derivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,679

Underlying: Common Stock · 24,679 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on December 10, 2022.

F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on December 10, 2022.

SEC source: 0001447362-21-000268 · wf-form4_163952988173021.xml · derivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,550

Underlying: Common Stock · 42,550 shares

Expires 2031-12-09

F2 · derivative.exercise_date: 25% of the shares shall vest on December 10, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.

SEC source: 0001447362-21-000268 · wf-form4_163952988173021.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,774

SEC source: 0001447362-21-000268 · wf-form4_163952988173021.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

SEC source: 0001447362-21-000227 · wf-form4_163294604538057.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,540

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 25, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $71.37 to $72.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001447362-21-000227 · wf-form4_163294604538057.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,966

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 25, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $70.37 to $71.36, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 423 shares acquired on August 31, 2021 under the Issuer's employee stock purchase plan.